Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

PURPOSE: Outcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure. We examined the additional prognostic value of circulating tumor DNA (ctDNA) before and during therapy for predicting patient outcomes. PAT...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Kurtz, David M., Scherer, Florian, Jin, Michael C., Soo, Joanne, Craig, Alexander F.M., Esfahani, Mohammad Shahrokh, Chabon, Jacob J., Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael S., Advani, Ranjana H., Levy, Ronald, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Meignan, Michel, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2018
Aiheet:
ORIGINAL REPORTS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161832/
https://ncbi.nlm.nih.gov/pubmed/30125215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.78.5246
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia